Association of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk Factors

Journal of the American College of Cardiology

Volumn 68, Issue 14, 2016, Pages 1509-1521

  Lee, Jane J ^a   Pedley, Alison ^a   Hoffmann, Udo ^b   Massaro, Joseph M ^c   Fox, Caroline S ^a,d  

^a FRAMINGHAM HEART STUDY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cardiovascular disease; computed tomography; epidemiology; fat attenuation; subcutaneous adipose tissue; visceral adipose tissue

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CORRELATIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; INTRAPERITONEAL FAT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SMOKING; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; TREND STUDY; WAIST CIRCUMFERENCE; ABDOMINAL FAT; ANATOMY AND HISTOLOGY; CARDIOVASCULAR DISEASES; PATHOLOGY; RISK FACTOR;

ABDOMINAL FAT; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84992028000     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.06.067     Document Type: Article

References (46)

1. 1 Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131 (2015), e29–e322.
2. 2 Mathers, C.D., Loncar, D., Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 3, 2006, e442.
3. 3 Fox, C.S., Massaro, J.M., Hoffmann, U., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116 (2007), 39–48.
4. 4 Maurovich-Horvat, P., Massaro, J., Fox, C.S., et al. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) 31 (2007), 500–506.
5. 5 Smith, J.D., Borel, A.L., Nazare, J.A., et al. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. J Clin Endocrinol Metab 97 (2012), 1517–1525.
6. 6 Kurukulasuriya, L.R., Stas, S., Lastra, G., et al. Hypertension in obesity. Med Clin North Am 95 (2011), 903–917.
7. 7 Ibrahim, M.M., Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11 (2010), 11–18.
8. 8 Rosenquist, K.J., Pedley, A., Massaro, J.M., et al. Visceral and subcutaneous fat quality and cardiometabolic risk. J Am Coll Cardiol Img 6 (2013), 762–771.
9. 9 Abraham, T.M., Pedley, A., Massaro, J.M., et al. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation 132 (2015), 1639–1647.
10. 10 Dawber, T.R., Kannel, W.B., Lyell, L.P., An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci 107 (1963), 539–556.
11. 11 Splansky, G.L., Corey, D., Yang, Q., et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 165 (2007), 1328–1335.
12. 12 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001), 2486–2497.
13. 13 Kannel, W.B., Sorlie, P., Some health benefits of physical activity. The Framingham Study. Arch Intern Med 139 (1979), 857–861.
14. 14 Lee, J.J., Britton, K.A., Pedley, A., et al. Adipose tissue depots and their cross-sectional associations with circulating biomarkers of metabolic regulation. J Am Heart Assoc, 5, 2016, e002936.
15. 15 Lee, J.J., Pedley, A., Hoffmann, U., et al. Cross-sectional associations of computed tomography (CT)-derived adipose tissue density and adipokines: the Framingham Heart Study. J Am Heart Assoc, 5, 2016, e002545.
16. 16 Levy, D., Ehret, G.B., Rice, K., et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 41 (2009), 677–687.
17. 17 Cui, J.S., Hopper, J.L., Harrap, S.B., Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 41 (2003), 207–210.
18. 18 Matsushita, Y., Nakagawa, T., Yamamoto, S., et al. Effect of longitudinal changes in visceral fat area on incidence of metabolic risk factors: the Hitachi health study. Obesity (Silver Spring) 21 (2013), 2126–2129.
19. 19 Wander, P.L., Boyko, E.J., Leonetti, D.L., et al. Change in visceral adiposity independently predicts a greater risk of developing type 2 diabetes over 10 years in Japanese Americans. Diabetes Care 36 (2013), 289–293.
20. 20 Sullivan, C.A., Kahn, S.E., Fujimoto, W.Y., et al. Change in intra-abdominal fat predicts the risk of hypertension in Japanese Americans. Hypertension 66 (2015), 134–140.
21. 21 Matsushita, Y., Nakagawa, T., Yamamoto, S., et al. Effect of longitudinal changes in visceral fat area and other anthropometric indices to the changes in metabolic risk factors in Japanese men: the Hitachi Health Study. Diabetes Care 35 (2012), 1139–1143.
22. 22 Rheaume, C., Arsenault, B.J., Dumas, M.P., et al. Contributions of cardiorespiratory fitness and visceral adiposity to six-year changes in cardiometabolic risk markers in apparently healthy men and women. J Clin Endocrinol Metab 96 (2011), 1462–1468.
23. 23 Shah, R.V., Murthy, V.L., Abbasi, S.A., et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. J Am Coll Cardiol Img 7 (2014), 1221–1235.
24. 24 Rosenquist, K.J., Massaro, J.M., Pedley, A., et al. Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. J Clin Endocrinol Metab 100 (2015), 227–234.
25. 25 Yeoh, A.J., Pedley, A., Rosenquist, K.J., Hoffmann, U., Fox, C.S., The association between subcutaneous fat density and the propensity to store fat viscerally. J Clin Endocrinol Metab 100 (2015), E1056–E1064.
26. 26 Porter, S.A., Massaro, J.M., Hoffmann, U., et al. Abdominal subcutaneous adipose tissue: a protective fat depot?. Diabetes Care 32 (2009), 1068–1075.
27. 27 McLaughlin, T., Lamendola, C., Liu, A., Abbasi, F., Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 96 (2011), E1756–E1760.
28. 28 Liu, J., Fox, C.S., Hickson, D.A., et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab 95 (2010), 5419–5426.
29. 29 Therkelsen, K.E., Pedley, A., Rosenquist, K.J., et al. Adipose tissue attenuation as a marker of adipose tissue quality: Associations with six-year changes in body weight. Obesity 24 (2015), 499–505.
30. 30 Sun, K., Kusminski, C.M., Scherer, P.E., Adipose tissue remodeling and obesity. J Clin Invest 121 (2011), 2094–2101.
31. 31 Ouchi, N., Parker, J.L., Lugus, J.J., Walsh, K., Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11 (2011), 85–97.
32. 32 Makki, K., Froguel, P., Wolowczuk, I., Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN inflamm, 2013, 2013, 139239.
33. 33 Despres, J.P., Lemieux, I., Abdominal obesity and metabolic syndrome. Nature 444 (2006), 881–887.
34. 34 Furlan, A., Fakhran, S., Federle, M.P., Spontaneous abdominal hemorrhage: causes, CT findings, and clinical implications. AJR Am J Roentgenol 193 (2009), 1077–1087.
35. 35 Trayhurn, P., Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev 93 (2013), 1–21.
36. 36 Murphy, R.A., Register, T.C., Shively, C.A., et al. Adipose tissue density, a novel biomarker predicting mortality risk in older adults. J Gerontol A Biol Sci Med Sci 69 (2014), 109–117.
37. 37 Baba, S., Jacene, H.A., Engles, J.M., et al. CT Hounsfield units of brown adipose tissue increase with activation: preclinical and clinical studies. J Nucl Med 51 (2010), 246–250.
38. 38 Hu, H.H., Chung, S.A., Nayak, K.S., et al. Differential computed tomographic attenuation of metabolically active and inactive adipose tissues: preliminary findings. J Comput Assist 35 (2011), 65–71.
39. 39 Despres, J.P., Lemieux, I., Bergeron, J., et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28 (2008), 1039–1049.
40. 40 Fujioka, S., Matsuzawa, Y., Tokunaga, K., et al. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes 15 (1991), 853–859.
41. 41 Leenen, R., van der Kooy, K., Droop, A., et al. Visceral fat loss measured by magnetic resonance imaging in relation to changes in serum lipid levels of obese men and women. Arterioscler Thromb 13 (1993), 487–494.
42. 42 Kanai, H., Tokunaga, K., Fujioka, S., et al. Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women. Hypertension 27 (1996), 125–129.
43. 43 Okauchi, Y., Nishizawa, H., Funahashi, T., et al. Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care 30 (2007), 2392–2394.
44. 44 Albu, J.B., Heilbronn, L.K., Kelley, D.E., et al. Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes 59 (2010), 627–633.
45. 45 Schaefer, E.J., Woo, R., Kibata, M., et al. Mobilization of triglyceride but not cholesterol or tocopherol from human adipocytes during weight reduction. Am J Clin Nutr 37 (1983), 749–754.
46. 46 Andersson, D.P., Eriksson Hogling, D., Thorell, A., et al. Changes in subcutaneous fat cell volume and insulin sensitivity after weight loss. Diabetes Care 37 (2014), 1831–1836.